LOGC LogicBio Therapeutics

LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock

LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
EN
01/10/2020

Underlying

LOGCLogicBio Therapeutics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LogicBio Therapeutics

 PRESS RELEASE
Free
LOGC LogicBio Therap...

LogicBio Therapeutics to Present at Upcoming Investor Conferences

LogicBio Therapeutics to Present at Upcoming Investor Conferences LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery today announced senior member of management will be presenting at upcoming investor conferences COO Kyle Chiang will participate in fireside chat at the Barclay’s Gene Editing and Gene Therapy Summit on Monday November 16, 2020 at 8:15 AM ET CEO Frederic Chereau will present at the Jeffries Virtual London Healthcare Conference Genetic...

November 12, 2020 1 EN
 PRESS RELEASE
Free
LOGC LogicBio Therap...

LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and...

LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update - IND for LB-001 in methylmalonic acidemia (MMA) cleared in August 2020, with first patient in Phase 1/2 SUNRISE trial expected to be enrolled in early 2021- Fast Track designation for LB-001 in MMA received in November 2020- First follow-on offering post-IPO closed in October 2020 LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a company dedicated to extending the reach of genetic medicine with pioneering targeted deliv...

November 9, 2020 1 EN
 PRESS RELEASE
Free
LOGC LogicBio Therap...

LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 f...

LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) Fast Track designation facilitates development of new therapies that treat serious conditions and fulfill unmet needs for patients LEXINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, announced today the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its clinical candidate, LB-00...

November 4, 2020 1 EN
 PRESS RELEASE
Free
LOGC LogicBio Therap...

LogicBio Therapeutics Announces Appointment of Veteran Biotech Executi...

LogicBio Therapeutics Announces Appointment of Veteran Biotech Executive Mariana Nacht, Ph.D., as Chief Scientific Officer and Kyle Chiang, Ph.D., Promoted to Chief Operating Officer LEXINGTON, Mass., Nov. 03, 2020 (GLOBE NEWSWIRE) -- (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today announced the appointment of Mariana Nacht, Ph.D., as chief scientific officer, effective Nov. 30, 2020, and the promotion of Kyle Chiang, Ph.D., to chief operating officer, effective Nov. 2, 2020. Dr. Nacht brings mor...

November 3, 2020 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
UEPS Net 1 U.E.P.S. ...
TCX TUCOWS INC. ... (+51)

InsiderInsights Weekly Tables: October 24, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TCX TUCOWS INC.
OFC CORPORATE OFFICE PROPERTIES TRUST
MCHX MARCHEX INC. CL B
HIG HARTFORD FINANCIAL SERVICES GROUP INC.
FPRX FIVE PRIME THERAPEUTICS INC.
CPRX CATALYST PHARMACEUTICALS
CLR CONTINENTAL RESOURCES INC.
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
PCYO PURE CYCLE CORP.
SAFT SAFETY INSURANCE GROUP INC.
GOVX GEOVAX LABS INC
MEDP MEDPACE HOLDINGS INC.
TRC TEJON RANCH CO.
ACNB ACNB CORP.
EDF STONE HARBOR EMERGING MARKETS INCOME FUND
OVLY OAK VALLEY BANCORP
RVT ROYCE VALUE TRUST INC.
WINA WINMARK CORP.
SOR SOURCE CAPITAL INC.
SELB SELECTA BIOSCIENCES
CADE CADENCE BANCORPORATION
GECC GREAT ELM CAPITAL CORP
AMZN AMAZON.COM INC.
EYEN EYENOVIA INC
TACO TACO CABANA INC.
SFBC SOUND FINANCIAL BANCORP INC
LOOP LOOP INDUSTRIES
FUND ROYCE FOCUS TRUST
FKWL INC.
NEON FRANKLIN WIRELESS CORP.
VTA NEONODE INC.
CI INVESCO DYNAMIC CREDIT OPPORTU
LOGC CIGNA CORPORATION
ETON LOGICBIO THERAPEUTICS
FAF ETON PHARMACEUTICALS
GOSS FIRST AMERICAN FINANCIAL CORPORATION
NML GOSSAMER BIO
PGEN NEUBERGER BERMAN MLP INCOME FUND INC.
EFT PRECIGEN INC
HGBL EATON VANCE FLOATING RATE INCOME TRUST
NSPR HERITAGE GLOBAL
FUBO INSPIREMD
RYES FUBOTV INC.
TARA PATRIOT MINEFINDERS INC.
ARQT PROTEON THERAPEUTICS INC
BIVI ARCUTIS BIOTHERAPEUTICS
HQL INC.
HQH BIOVIE INC.
TEKLA LIFE SCIENCES INVESTORS
H&Q HEALTHCARE INVESTORS
10/25/20 October 25, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch